Fetal Adrenal Suppression Due to Maternal Corticosteroid Use: Case Report

Journal Title: Journal of Clinical Research in Pediatric Endocrinology - Year 2011, Vol 3, Issue 3

Abstract

During pregnancy, steroids are usually used in maternal diseases such as adrenal failure or other autoimmune diseases, e.g. idiopathic thrombocytopenic purpura (ITP), Crohn’s disease, systemic lupus erythematosus, dermatomyositis, scleroderma, Addison’s disease and hyperemesis gravidarum, HELLP syndrome. Endogenous or exogenous maternal steroids are metabolized by the placental enzyme 11 beta-hydroxy steroid dehydrogenase type 2. Prednisolone and methylprednisolone are highly sensitive to this enzyme, while dexamethasone and betamethasone are less well metabolized. Steroids which can cross the placental barrier are administered in cases like fetal lupus, congenital adrenal hyperplasia and for enhancement of fetal lung maturation, whereas steroids used in maternal diseases are usually the ones with low affinity to the placenta; however, in case of long-term use or in high doses, placental enzyme saturation occurs and thus, resulting in fetal adrenal suppression. Antenatal steroids can lead to low birth weight, as observed in our patient. Here, we report a case with fetal adrenal suppression due to maternal methylprednisolone use presenting with early hypoglycaemia and late hyponatremia in neonatal period and requiring three-month replacement therapy.

Authors and Affiliations

Selim Kurtoğlu, Dilek Sarıcı, Mustafa Ali Akın, Ghaniya Daar, Levent Korkmaz, Şeyma Memur

Keywords

Related Articles

A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes

Background: Insulin glargine provides effective glycemic control when administered at bedtime in adults. Objective: This study aims to investigate whether insulin glargine is equally effective if administered in the mor...

Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy <br />

Objective: The purpose of this study was to compare the efficacy and safety of insulin glargine and detemir with NPH insulin in children and adolescents with type 1 diabetes mellitus (DM). Methods: Thirty four children...

Physiology of Growth Hormone Secretion

Growth hormone (GH) is secreted in a pulsatile fashion from the anterior pituitary gland. The synthesis and the secretion of GH are regulated mainly by two hypothalamic neuropeptides, the growth hormone-releasing hormone...

Melnick-Needles Syndrome Associated with Growth Hormone Deficiency: A Case Report

Melnick-Needles syndrome is an X-linked dominant bone dysplasia characterized by a typical facies (exophthalmos, full cheeks, micrognathia, and malalignment of teeth), flaring of the metaphyses of long bones, s-like curv...

Diagnosis of Growth Hormone Deficiency: the role of Growth Hormone (GH), Insulin-Like Growth Factor (IGF-I) and IGF-Binding Protein (IGFBP-3)

Despite dramatic changes in the treatment of growth hormone (GH) deficiency from cadaveric pituitary growth hormone to recombinant human growth hormone, the diagnosis of idiopathic growth hormone deficiency remains a cha...

Download PDF file
  • EP ID EP85896
  • DOI -
  • Views 126
  • Downloads 0

How To Cite

Selim Kurtoğlu, Dilek Sarıcı, Mustafa Ali Akın, Ghaniya Daar, Levent Korkmaz, Şeyma Memur (2011). Fetal Adrenal Suppression Due to Maternal Corticosteroid Use: Case Report. Journal of Clinical Research in Pediatric Endocrinology, 3(3), 160-162. https://europub.co.uk/articles/-A-85896